Arsenic Exposure Reduction and Chronic Disease Mortality

Area of Science:

• Environmental Health
• Toxicology
• Epidemiology

Background:

• Chronic arsenic exposure via drinking water is a significant public health concern, linked to increased mortality from chronic diseases.
• Limited evidence exists on the health benefits of reducing arsenic exposure in affected populations.

Purpose of the Study:

• To investigate the association between reduced arsenic exposure, measured by urinary arsenic levels, and mortality risk from chronic diseases, including cancer and cardiovascular disease (CVD).

Main Methods:

• Prospective cohort study in Bangladesh (n=10,977) with repeated measurements of urinary arsenic levels over time (2000-2018).
• Community-level mitigation efforts led to reduced arsenic exposure.
• Time-varying Cox regression and restricted cubic spline analyses were used to assess mortality risk associated with changes in arsenic exposure.

Main Results:

• Each interquartile range (IQR) decrease in urinary arsenic was associated with a 22% reduction in chronic disease mortality, 20% in cancer mortality, and 23% in CVD mortality.
• Participants whose urinary arsenic levels declined below the median showed significantly lower mortality rates compared to those with consistently high levels.
• Reductions in arsenic exposure were consistently linked to lower mortality, while increases were associated with higher risk.

Conclusions:

• Reduced arsenic exposure, even after chronic exposure, is associated with significant reductions in mortality from chronic diseases.
• These findings highlight the importance of public health interventions aimed at lowering arsenic levels in drinking water to improve population health outcomes.